Recordati Industria Chimica e Farmaceutica S.p.A. (BIT: REC)
Italy
· Delayed Price · Currency is EUR
50.05
+0.05 (0.10%)
Nov 19, 2024, 11:16 AM CET
REC Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 2,269 | 2,082 | 1,853 | 1,580 | 1,449 | 1,482 | Upgrade
|
Revenue Growth (YoY) | 11.68% | 12.36% | 17.29% | 9.06% | -2.23% | 9.59% | Upgrade
|
Cost of Revenue | 666.44 | 600.76 | 516.93 | 427.73 | 406.83 | 436.9 | Upgrade
|
Gross Profit | 1,603 | 1,482 | 1,336 | 1,152 | 1,042 | 1,045 | Upgrade
|
Selling, General & Admin | 633.09 | 601.51 | 572.3 | 481.01 | 422.01 | 445.87 | Upgrade
|
Research & Development | 278.36 | 255.75 | 220.1 | 166.14 | 146.24 | 129.68 | Upgrade
|
Other Operating Expenses | -7.09 | -2.25 | -0.5 | 0.65 | -1.71 | -1.61 | Upgrade
|
Operating Expenses | 904.36 | 855.01 | 791.91 | 647.8 | 566.55 | 573.94 | Upgrade
|
Operating Income | 698.45 | 626.56 | 544.47 | 504.55 | 475.49 | 471.01 | Upgrade
|
Interest Expense | -81.15 | -74.46 | -34.45 | -20.9 | -17.5 | -20.1 | Upgrade
|
Interest & Investment Income | 5.83 | 4.18 | - | - | 0.02 | - | Upgrade
|
Currency Exchange Gain (Loss) | -0.42 | 2.16 | -5.8 | -5.82 | 4.28 | -0.74 | Upgrade
|
EBT Excluding Unusual Items | 622.71 | 558.44 | 504.22 | 477.83 | 462.29 | 450.17 | Upgrade
|
Merger & Restructuring Charges | -70.55 | -67.95 | -93.47 | -11.73 | - | -1.42 | Upgrade
|
Asset Writedown | -4.92 | -0.37 | -10.93 | -0.05 | - | -0.45 | Upgrade
|
Other Unusual Items | -4.13 | 0.91 | 1.62 | -2.69 | -6.63 | -4.15 | Upgrade
|
Pretax Income | 543.12 | 491.04 | 401.44 | 463.35 | 455.66 | 444.14 | Upgrade
|
Income Tax Expense | 120 | 101.82 | 89.1 | 77.38 | 100.63 | 75.28 | Upgrade
|
Earnings From Continuing Operations | 423.12 | 389.21 | 312.34 | 385.97 | 355.03 | 368.87 | Upgrade
|
Minority Interest in Earnings | - | - | - | - | -0.04 | -0.04 | Upgrade
|
Net Income | 423.12 | 389.21 | 312.34 | 385.97 | 354.98 | 368.83 | Upgrade
|
Net Income to Common | 423.12 | 389.21 | 312.34 | 385.97 | 354.98 | 368.83 | Upgrade
|
Net Income Growth | 12.72% | 24.61% | -19.08% | 8.73% | -3.75% | 18.07% | Upgrade
|
Shares Outstanding (Basic) | 206 | 206 | 206 | 206 | 206 | 205 | Upgrade
|
Shares Outstanding (Diluted) | 209 | 209 | 209 | 209 | 209 | 209 | Upgrade
|
Shares Change (YoY) | 0.01% | 0.04% | -0.01% | 0.01% | -0.01% | -0.00% | Upgrade
|
EPS (Basic) | 2.05 | 1.89 | 1.52 | 1.87 | 1.73 | 1.80 | Upgrade
|
EPS (Diluted) | 2.02 | 1.86 | 1.49 | 1.85 | 1.70 | 1.76 | Upgrade
|
EPS Growth | 12.70% | 24.56% | -19.07% | 8.72% | -3.74% | 18.07% | Upgrade
|
Free Cash Flow | 496.97 | 455.63 | 437.8 | 469.8 | 382.31 | 296.61 | Upgrade
|
Free Cash Flow Per Share | 2.38 | 2.18 | 2.09 | 2.25 | 1.83 | 1.42 | Upgrade
|
Dividend Per Share | 1.230 | 1.200 | 1.150 | 1.100 | 1.050 | 1.000 | Upgrade
|
Dividend Growth | 5.13% | 4.35% | 4.55% | 4.76% | 5.00% | 8.70% | Upgrade
|
Gross Margin | 70.63% | 71.15% | 72.11% | 72.93% | 71.92% | 70.52% | Upgrade
|
Operating Margin | 30.78% | 30.09% | 29.38% | 31.93% | 32.82% | 31.79% | Upgrade
|
Profit Margin | 18.65% | 18.69% | 16.85% | 24.43% | 24.50% | 24.89% | Upgrade
|
Free Cash Flow Margin | 21.90% | 21.88% | 23.62% | 29.73% | 26.39% | 20.02% | Upgrade
|
EBITDA | 837.18 | 757.12 | 659.21 | 592.2 | 558.98 | 538.4 | Upgrade
|
EBITDA Margin | 36.89% | 36.36% | 35.57% | 37.48% | 38.58% | 36.33% | Upgrade
|
D&A For EBITDA | 138.74 | 130.56 | 114.73 | 87.65 | 83.49 | 67.4 | Upgrade
|
EBIT | 698.45 | 626.56 | 544.47 | 504.55 | 475.49 | 471.01 | Upgrade
|
EBIT Margin | 30.78% | 30.09% | 29.38% | 31.93% | 32.82% | 31.79% | Upgrade
|
Effective Tax Rate | 22.09% | 20.74% | 22.20% | 16.70% | 22.08% | 16.95% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.